112 related articles for article (PubMed ID: 6437863)
21. Human breast carcinoma xenografts in nude mice.
Li Z; Huang X; Li J; Ke Y; Yang L; Wang Y; Yao L; Lu Y
Chin Med J (Engl); 2002 Feb; 115(2):222-6. PubMed ID: 11940336
[TBL] [Abstract][Full Text] [Related]
22. [Sensitivity of human tumor cells in culture to mitomycin C and thiophosphamide].
Tolkacheva EN; Timofeevskaia EA
Antibiotiki; 1973 Mar; 18(3):223-7. PubMed ID: 4202930
[No Abstract] [Full Text] [Related]
23. [Colony formation of solid tumors in in vitro colony assay (human tumor stem cell assay)].
Inoue K; Arakawa M; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Aiba K; Domyo M; Miyamoto H; Ikeda K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2128-32. PubMed ID: 6764097
[TBL] [Abstract][Full Text] [Related]
24. [Comparative electron microscopic study of cancer cell differentiation in the primary tumor and the metastases].
Delektorskaia VV
Arkh Patol; 1985; 47(9):45-53. PubMed ID: 4074157
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
27. A dominated and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice.
Aabo K; Roed H; Vindeløv LL; Spang-Thomsen M
Cancer Res; 1994 Jun; 54(12):3295-9. PubMed ID: 8205552
[TBL] [Abstract][Full Text] [Related]
28. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
[TBL] [Abstract][Full Text] [Related]
29. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
30. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
Vadgama JV; Wu Y; Shen D; Hsia S; Block J
Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
[TBL] [Abstract][Full Text] [Related]
31. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models.
Schluep T; Hwang J; Cheng J; Heidel JD; Bartlett DW; Hollister B; Davis ME
Clin Cancer Res; 2006 Mar; 12(5):1606-14. PubMed ID: 16533788
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Kelner MJ; McMorris TC; Rojas RJ; Trani NA; Estes L
Cancer Chemother Pharmacol; 2002 May; 49(5):412-8. PubMed ID: 11976836
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of amrubicin with a 5 day administration schedule in a mouse model].
Noguchi T; Ichii S; Morisada S; Yamaoka T; Yanagi Y
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1305-12. PubMed ID: 10478184
[TBL] [Abstract][Full Text] [Related]
34. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
[TBL] [Abstract][Full Text] [Related]
35. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
36. [Medical treatment of some solid tumors].
Lattanzi A
Clin Ter; 1979 Jan; 88(2):113-38. PubMed ID: 371905
[No Abstract] [Full Text] [Related]
37. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
38. [Human amniotic fluid research. In vitro antineoplastic activity].
Gheri Bryk S; Marchesi L; Di Preta F
Arch Ital Anat Embriol; 1981; 86(4):363-84. PubMed ID: 6890333
[No Abstract] [Full Text] [Related]
39. [A study of human breast carcinoma xenografts in nude mice].
Li Z; Huang X; Li J
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):865-8. PubMed ID: 11218886
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
Schiller JH; Bittner G
Clin Cancer Res; 1999 Dec; 5(12):4287-94. PubMed ID: 10632372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]